Research Update: Unocal Corp. Oct 02

  • ID: 1886711
  • October 2002
  • Standard & Poors
1 of 3

On Oct. 1, 2002, Standard & Poor's Ratings Services assigned its 'BBB+' senior unsecured rating to El Segundo, Calif.-based, Union Oil Co. of California's $400 million 5.05% senior notes due 2012, guaranteed by independent oil company Unocal Corp. (BBB+/Stable/A-2) At the same time, Standard & Poor's affirmed all ratings on Union Oil and its parent Unocal. The outlook on Unocal remains stable. Net proceeds from the offering will be used to repay outstanding commercial paper borrowings. As a result of the eventual repurchase of substantially all of its outstanding commercial paper during the fourth quarter, Unocal will have improved its liquidity by extending its debt maturities. In addition to operating cash flow, Unocal's sources of liquidity include full availability on...

Companies mentioned in this report are: Unocal Corp.
Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Product Type: Research Update
Research updates complement media releases. They offer more depth and detail than summary analyses by incorporating all information published in the media release. They are more up to date than summaries in that they are published simultaneously with media releases.

Note: Product cover images may vary from those shown
2 of 3

Unocal Corp.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.